Teachers React To The News
Arlington ISD is planning to offer a third-party clinic network conveniently located within the district, anticipated to open in the spring of 2027.
Continue reading Arlington ISD To Open Onsite Clinic
Starting July 1, 2026, Medicare will begin a short-term demonstration, called the Medicare GLP-1 Bridge, that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs.
Continue reading Medicare Tinkers With GLP-1 Drugs
By Kashif Baloch – President @ Hello Support Network — Insurance Marketing — Medicare | ACA | Auto | FE | Home Services
CMS has officially released the 2027 Agent & Broker compensation rates for Medicare Advantage and Part D plans.
Continue reading Medicare Brokerage Brings BIG BUCKS
FILE PHOTO: A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. REUTERS/Hollie Adams/Brendan McDermid/Combination/File Photo
Reuters – June 2, 2026 -mBy Amina Niasse
NEW YORK, June 2 (Reuters) – Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound in its employee health plan effective July 1, according to materials viewed by Reuters on Tuesday.
Continue reading Cigna Drops Coverage of GLP-1 Obesity Drugs for Its Own Employees
By Bill Rusteberg
No one can argue ICHRA market share is growing driven by market demand. Statistics prove it. No question about it. There’s a clear winner in that debate.
Continue reading ICHRA: Are Brokers Driving Market Demand Or Reacting To It?